š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolera...
Status
Active Not Recruiting
Location
Beverly Hills Institute of Ophthalmology
Start Date
2025-01-10
Trial ID
NCT06852768
Treatments Being Tested
Efficacy and acceptability of two new artificial tears following two weeks ...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00756678
Treatments Being Tested
The purpose of this study is to evaluate the pharmacodynamics, safety, and ...
Status
Recruiting
Location
DTX-168-201 Study Site
Start Date
2025-07-30
Trial ID
NCT07024693
Treatments Being Tested
This study is for patients have been using prostaglandin analogue eye drops...
Status
Unknown
Location
Seoul National University Bundang Hospital
Start Date
2022-02-15
Trial ID
NCT05279716
Treatments Being Tested
This study aims to compare the short-term effect of oxymetazoline 0.1% (Upn...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT07390578
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
To investigate the dose-response relationship of DE-104 ophthalmic solution...
Status
Completed
Location
Sall Research Medical Center
Start Date
2008-03
Trial ID
NCT00650338
The TRANQUILITY Trial: Multi-Center Randomized, Double-Masked, Parallel Des...
Status
Completed
Location
University Clinical Health
Start Date
2020-11-21
Trial ID
NCT04674358
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of Besiv...
Status
Terminated
Location
Bausch & Lomb Incorporated
Start Date
2011-05
Trial ID
NCT01330355
Treatments Being Tested